Fallon John A.'s Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Nov 14, 2025
- Accession no.
- 0001560152-25-000004
- Filed
- Nov 14, 2025
- Trade date
- Nov 12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.65M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fallon John A.CIK 0001560152 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Common Stock | MOption exerciseAcquired | +15,000 | $16.49 | +$247,350 | 79,634 | Direct | |
| Nov 12, 2025 | Common Stock | MOption exerciseAcquired | +19,853 | $9.33 | +$185,228.49 | 99,487 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −34,853 | $47.21 | −$1,645,410.13 | 64,634 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 0 | Direct | |
| Nov 12, 2025 | Common Stock | MOption exerciseDisposed | −19,853 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.